Circular RNAs as disease modifiers of complex neurologic disorders
- PMID: 40453669
- PMCID: PMC12122743
- DOI: 10.3389/fphar.2025.1577496
Circular RNAs as disease modifiers of complex neurologic disorders
Abstract
Circular RNAs are a large class of non-coding RNA molecules, conserved across species and produced by back-splicing. While their molecular functions are still elusive, the ones primarily retained in the nucleus are usually associated to regulation of transcription and mRNA processing patterns. Instead, the majority, are transported to the cytoplasm where they elicit micro-RNA (miRNA) or RNA binding protein (RBP)-sponging functions, or could be translated. CircRNAs are abundantly expressed in brain tissue, where they do not only act as regulators of brain development and physiology, but can also contribute to complex neurological conditions. In fact, deregulated circRNA expression levels were described in neurodevelopmental and neurodegenerative disorders, like Alzheimer's disease, Parkinson's disease and Huntington's disease. Because of their described roles in pathology, these molecules may not only represent possible disease bio-markers, but they could even function as disease modifiers. As such, they could be targeted or protected in search of novel routes of therapeutic intervention. In this review, we highlight recent developments in the field, first discussing circRNAs involved in physiologic brain development and function, then reviewing studies that implicate circRNAs in neurodevelopmental and neurodegenerative disorders, with major attention to experimental studies exploring circRNA function and their role in neuropathologic processes. Such experimental strategies are mainly based on depletion or over-expression approaches and provide important insights into the modulatory potential of these molecules. They are relevant for clinical translation of basic research findings to drug development, possibly generating a positive impact for patients' quality of life.
Keywords: alternative splicing; circRNA; neurodegeneration; neurodevelopment; non-coding RNA.
Copyright © 2025 Galli, Vinciguerra, Biagioli and Morandell.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Circular RNAs are a novel type of non-coding RNAs in ROS regulation, cardiovascular metabolic inflammations and cancers.Pharmacol Ther. 2021 Apr;220:107715. doi: 10.1016/j.pharmthera.2020.107715. Epub 2020 Oct 24. Pharmacol Ther. 2021. PMID: 33141028 Free PMC article. Review.
-
Review on circular RNAs and new insights into their roles in cancer.Comput Struct Biotechnol J. 2021 Jan 22;19:910-928. doi: 10.1016/j.csbj.2021.01.018. eCollection 2021. Comput Struct Biotechnol J. 2021. PMID: 33598105 Free PMC article. Review.
-
Insights Into the Role of CircRNAs: Biogenesis, Characterization, Functional, and Clinical Impact in Human Malignancies.Front Cell Dev Biol. 2021 Feb 5;9:617281. doi: 10.3389/fcell.2021.617281. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33614648 Free PMC article. Review.
-
Circular RNAs in neurological conditions - computational identification, functional validation, and potential clinical applications.Mol Psychiatry. 2025 Apr;30(4):1652-1675. doi: 10.1038/s41380-025-02925-1. Epub 2025 Feb 17. Mol Psychiatry. 2025. PMID: 39966624 Free PMC article. Review.
-
Circ-LocNet: A Computational Framework for Circular RNA Sub-Cellular Localization Prediction.Int J Mol Sci. 2022 Jul 26;23(15):8221. doi: 10.3390/ijms23158221. Int J Mol Sci. 2022. PMID: 35897818 Free PMC article.
References
-
- Arizaca Maquera K. A., Welden J. R., Margvelani G., Miranda Sardón S. C., Hart S., Robil N., et al. (2023). Alzheimer’s disease pathogenetic progression is associated with changes in regulated retained introns and editing of circular RNAs. Front. Mol. Neurosci. 16, 1141079. 10.3389/fnmol.2023.1141079 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials